GGrantIndex
Sort

39,280 grants matching leukemia

Genomics of Acute Myelogenous Leukemia (AML): Somatic Mutations & Consequences

$449,473
Timothy J Ley · Washington University · P01 · FY2011 · CA

Studies of other risk factors for radiosensitive tumors

$449,455
Amy Berrington · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA

Molecular Inhibition of Apoptosis Inhibitors

$449,324
John C Reed · University Of California, San Diego · P01 · FY2014 · CA

Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE

$449,314
Aasthaa Bansal · University Of Washington · R37 · FY2020 · CA

Retroviral Coded Functions

$449,285
Maxine L Linial · Fred Hutchinson Cancer Research Center · R01 · FY2006 · CA

Targeted Therapies for Richters Transformation

$449,278
Rosa Lapalombella · Ohio State University · R01 · FY2019 · CA

Molecular Pathogenesis of AF10-Rearranged Leukemias

$449,276
Aniruddha J. Deshpande · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA

Targeting the PD-1H (VISTA) Pathway to Overcome Immunosuppression in Acute Myeloid Leukemia

$449,222
Xue Han · Ohio State University · R37 · FY2025 · CA

Role of CXCR3-CXCL10 signaling in T-ALL CNS disease

$449,218
Ksenia Matlawska-Wasowska · University Of Alabama At Birmingham · R01 · FY2024 · CA

Role of CXCR3-CXCL10 signaling in T-ALL CNS disease

$449,218
Ksenia Matlawska-Wasowska · University Of Alabama At Birmingham · R01 · FY2025 · CA

Runx1 Haplodeficiency, Endocytosis and Vesicle transport

$449,209
A Koneti Rao · Temple Univ Of The Commonwealth · R01 · FY2021 · HL

Runx1 Haplodeficiency, Endocytosis and Vesicle transport

$449,209
A Koneti Rao · Temple Univ Of The Commonwealth · R01 · FY2020 · HL

Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE

$449,121
Aasthaa Bansal · University Of Washington · R37 · FY2019 · CA

KIR and HLA in cis and trans cooperatively shape human NK education

$449,000
Katharine C Hsu · Sloan-Kettering Inst Can Research · R01 · FY2020 · AI

Regulation and Targets of the DNA Damage Checkpoint

$448,957
David P Toczyski · University Of California, San Francisco · R01 · FY2012 · GM

Strategies to improve the adoptive transfer of T cells

$448,945
Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA

Targeted therapy for t(8;21)+ AML

$448,823
Stephen David Nimer · University Of Miami School Of Medicine · R01 · FY2025 · CA

Cellular and functional impact of SAMD9L mutations on hematopoiesis and myelodysplasia

$448,750
Jeffery M Klco · St. Jude Children'S Research Hospital · R01 · FY2020 · HL

Cellular and functional impact of SAMD9L mutations on hematopoiesis and myelodysplasia

$448,750
Jeffery M Klco · St. Jude Children'S Research Hospital · R01 · FY2019 · HL

Cellular and functional impact of SAMD9L mutations on hematopoiesis and myelodysplasia

$448,750
Jeffery M Klco · St. Jude Children'S Research Hospital · R01 · FY2023 · HL

Cellular and functional impact of SAMD9L mutations on hematopoiesis and myelodysplasia

$448,750
Jeffery M Klco · St. Jude Children'S Research Hospital · R01 · FY2021 · HL

Sleep Apnea in Survivors of Childhood Cancer Treated with Thoracic Radiation (APNEA)

$448,750
Kevin R Krull · St. Jude Children'S Research Hospital · R01 · FY2020 · CA

Cellular and functional impact of SAMD9L mutations on hematopoiesis and myelodysplasia

$448,750
Jeffery M Klco · St. Jude Children'S Research Hospital · R01 · FY2022 · HL

Brain Age in Adult Survivors of Childhood Leukemia and CNS Tumor

$448,748
Melissa M Hudson · St. Jude Children'S Research Hospital · U01 · FY2021 · CA

Pathogenesis and Chemotherapy of Herpesvirus Infection

$448,678
Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI